SLC6A14 and cancer: In support of the contribution of SLC6A14‐mediated glutamine metabolism to cancer stemness, its downstream metabolite αKG rescued the sphere and organoid formation of MCF7 cells and PDO from the suppression by αMT (Figure 7D).